Look for:

INNATE PHARMA SA


ISIN:
FR0010331421
WKN:
-

2024/06/25 22:02:01
Price
1.976 EUR
Difference -1.20% (-0.02)

General attributes

ISINFR0010331421
SymbolIPH
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)160 EUR
BenchmarkCAC 40 INDEX

Market data

Bid (Bid size)1.956 EUR (512)
Ask (Ask size)1.994 EUR (502)
Open1.976 EUR
High1.976 EUR
Low1.976 EUR
Close (prev. day)2.00 EUR
VWAP2.07 EUR
Volume (pcs)-
Trading volume-
Number of trades1
Last size-

Futures and Options

Related Futures0
Related Options-
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/06/25 22:02:01
Price
1.976 EUR
Difference -1.20% (-0.02)

General attributes

ISINFR0010331421
SymbolIPH
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)160 EUR
BenchmarkCAC 40 INDEX

Market data

Bid (Bid size)1.956 EUR (512)
Ask (Ask size)1.994 EUR (502)
Open1.976 EUR
High1.976 EUR
Low1.976 EUR
Close (prev. day)2.00 EUR
VWAP2.07 EUR
Volume (pcs)-
Trading volume-
Number of trades1
Last size-

Performance and Risk

6m1y3y
Perf (%)-19.35%-31.97%-29.87%
Perf (abs.)-0.48-0.94-0.85
Beta0.920.830.96
Volatility44.3747.2264.98
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)2.054 EUR (311)
Ø price 30 days | Ø volume 30 days (pcs.)2.405 EUR (203)
Ø price 100 days | Ø volume 100 days (pcs.)2.306 EUR (213)
Ø price 250 days | Ø volume 250 days (pcs.)2.452 EUR (425)
YTD High | date2.750 EUR (2024/01/04)
YTD Low | date2.000 EUR (2024/06/24)
52 Weeks High | date3.025 EUR (2023/09/04)
52 Weeks Low | date2.000 EUR (2024/06/24)

Arbitrage views

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Tradegate2024/06/2522:021.976 EUR0.001
Stuttgart2024/06/2515:431.936 EUR0.0010
Munich2024/06/2508:082.055 EUR0.002
London Stock Exchange European Trade Reporting2024/06/2517:301.9765 EUR0.002
Frankfurt2024/06/2508:091.972 EUR0.002
FINRA other OTC Issues2024/06/1316:262.49 USD0.001
Euronext Paris2024/06/2517:351.97 EUR0.11174
Duesseldorf2024/06/2508:111.984 EUR0.003
Berlin2024/06/2508:081.972 EUR0.003

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=137609&ID_TYPE_IMAGE_LOGO=2

Contact Details

INNATE PHARMA SA
- -
- - - -
Telefon: -
Fax: -
E-mail: -

Company Profile

-

Board of directors

Irina Staatz-GranzerChairman of Supervisory Board
Jean-Yves BlayMember of Supervisory Board
Olivier MartinezMember of Supervisory Board
Sally BennettMember of Supervisory Board
Véronique ChabernaudMember of Supervisory Board
Gilles BrissonMember of Supervisory Board
Pascale BoisselMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. For more details please read our Data protection policy.

INFORMATION FOR CORPORATE AND INSTITUTIONAL CLIENTS

Any information, material and services regarding financial instruments and securities provided by Erste Group Bank AG or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites”) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions (the “Interested Party“).

The publication and distribution of information as well as offering and selling of products and services described on the Websites is prohibited by law in some jurisdictions. For this reason, persons in countries in which the publication as well as the offering and selling of products and services described on the Websites are not permitted by law, must not enter the Websites and/or acquire the products displayed on the Websites.

Neither Erste Group nor any third party shall offer access to the Websites or offer the products to especially, but not limited to citizen/residents of the United States and “U.S. person” (as defined in Regulation S under the US Securities Act 1933 as amended). For this reason, the distribution or redistribution of the information, materials and products into United States or into any other jurisdiction where it is not permitted under the applicable law, as well as to the citizens/residents of these countries shall be prohibited. The securities displayed on the Websites have not been and will not be registered under the US Securities Act of 1933 and trading in the securities has not been approved for purposes of the US Commodities Exchange Act of 1936. For this reason the securities may, inter alia, not be offered, sold or delivered within the United States or, for the account and benefit of U.S. persons.

The Interested Party is solely responsible to examine, whether he may enter the Websites under the law applicable to it. Erste Group shall not be responsible for the distribution of content of any of the Websites to individuals or entities which provide false information about their right to enter the Websites. For this reason Erste Group shall not be liable for any legal claims or damages which may result from the unauthorized entering or reading of the Websites.

By agreeing to this hereto, the Interested Party confirms that
(i) It has read, understood and accepted this Information and the Disclaimer;
(ii) It informed itself about any possible legal restriction and warrants that it is not restricted or prohibited to enter the Websites according to any law applicable; and
(iii) It does not make available the contents of the Websites to any person who is not qualified by law to enter the Websites.
(iV) It is no consumer.